Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Ephrin A3 Antibodies:
anti-Rat (Rattus) Ephrin A3 Antibodies:
anti-Human Ephrin A3 Antibodies:
Go to our pre-filtered search.
Human Polyclonal Ephrin A3 Primary Antibody for ELISA, WB - ABIN1533774
Kozlosky, Maraskovsky, McGrew, VandenBos, Teepe, Lyman, Srinivasan, Fletcher, Gayle, Cerretti: Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins. in Oncogene 1995
Show all 3 references for ABIN1533774
Human Polyclonal Ephrin A3 Primary Antibody for ELISA - ABIN1995973
Prevost, Woulfe, Tanaka, Brass: Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred. in Proceedings of the National Academy of Sciences of the United States of America 2002
Human Polyclonal Ephrin A3 Primary Antibody for ICC, IF - ABIN4308737
Cha, Lee, Han, Kim, Kang, Choi, Cho: MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis. in The Prostate 2016
The ephrin-A2 (show EFNA2 Antibodies)/-A3 DKO mice have utility as a novel ASD (show GUSB Antibodies) model with an emphasis on sensory abnormalities and restricted, repetitive behavioral symptoms.
Ephrin-A2 (show EFNA2 Antibodies) and -A3 are negative regulators of the proliferative and neurogenic potentials of Muller cells.
Ephrin-A3 suppresses Wnt (show WNT2 Antibodies) signaling to control retinal stem cell potency.
Downregulation of the EphA4 (show EPHA4 Antibodies) receptor via siRNA transfection reduced the repulsive effect of ephrin-A3, indicating that EphA4 (show EPHA4 Antibodies) mediates at least in part the repulsive effect of ephrin-A3.
Data show that a number of Eph (show EPHA1 Antibodies) receptors and ephrins were expressed in hematopoietic stem cells.
Ephrin-A3 is localized on astrocytic processes that envelop spines. Activation of EphA4 (show EPHA4 Antibodies) by ephrin-A3 caused spine retraction; inhibiting ephrin/EphA4 (show EPHA4 Antibodies) interactions distorted spine shape and organization in hippocampal slices.
Organ of Corti and spiral ganglion showed strong expression of ephrin-A3, ephrin-B2 (show EFNB2 Antibodies) and ephrin-B3 (show EFNB3 Antibodies). In lateral wall, ephrin-A3 and ephrin-B2 (show EFNB2 Antibodies) were strongly expressed. Ephrin-A3 was strongly expressed in utricular and saccular sensory epithelia.
Results demonstrate that neurons expressing different odorant receptors express different levels of ephrin-A3 and -A5 protein (show NRP1 Antibodies) on their axons.
In mice deficient for ephrin-A2, A3 and A5, eye-specific inputs segregated but shape and location of eye-specific layers were profoundly disrupted. Ephrin-As and neural activity act together to control patterning of eye-specific retinogeniculate layers.
Whole-mount in situ hybridization revealed overlapping expression of the Epha1 (show EPHA1 Antibodies) receptor and its high-affinity ligands ephrin A1 (Efna1 (show EFNA1 Antibodies)) and ephrin A3 (Efna3) in the primitive streak and the posterior paraxial mesoderm during early mouse development.
Results show that EFNA3 serves as a tumor suppressor in malignant peripheral nerve sheath tumor cells and it may play a critical role in the FAK signaling and VEGF-associated tumor angiogenesis pathway.
The present study provides evidence that microglia upregulates endothelial ephrin-A3 and ephrin-A4 (show EFNA4 Antibodies) to facilitate in vitro angiogenesis of brain endothelial cells, which is mediated by microglia-released TNF-alpha (show TNF Antibodies).
The interaction between ephrin-As, Eph (show EPHA1 Antibodies) receptors and integrin alpha3 is plausibly important for the crosstalk between Eph (show EPHA1 Antibodies) and integrin signalling pathways at the membrane protrusions and in the migration of brain cancer cells.
EphA2 (show EPHA2 Antibodies)/ephrin-A3 interactions may play a role in the localization and network of Langerhans cells in the epithelium and in the regulation of their trafficking.
analysis of molecular surfaces in ephrin-A5 (show EFNA5 Antibodies) essential for a functional interaction with EphA3 (show EPHA3 Antibodies)
Increasing ephrin-A expression enhances T-cell interactions not only with purified integrin ligands but also endothelial cells, while EphA activation down-regulates these interactions.
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase (show RET Antibodies) ligand Ephrin-A3.
EphA3 (show EPHA3 Antibodies) mutants with constitutively-released kinase domains efficiently support shedding, even when their kinase is disabled. Our data suggest that this phosphorylation-activated conformational switch of EphA3 (show EPHA3 Antibodies) directly controls ADAM-mediated shedding.
This gene encodes a member of the ephrin (EPH) family. The ephrins and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, especially in the nervous system and in erythropoiesis. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. This gene encodes an EFNA class ephrin.
, EHK1 ligand
, EPH-related receptor tyrosine kinase ligand 3
, eph-related receptor tyrosine kinase ligand 3
, ligand of eph-related kinase 3